TENM4: A Potential Drug Target and Biomarker for KIAA1302 (G26011)

TENM4: A Potential Drug Target and Biomarker for KIAA1302

Kallikrein-related peptidases (KAPs) are a family of serine proteases that regulate various physiological processes in the body, including blood clotting, inflammation, and tissue repair. The KIAA1302 protein, also known as tenpinin-4 (TENM4), is a type of KAP that is expressed in various tissues and plays a crucial role in the regulation of blood clotting. However, despite its importance, TENM4 is still an untargeted protein, and its functions and interactions with other proteins are not well understood.

The aim of this article is to summarize the current understanding of TENM4, its potential drug targets, and its potential as a biomarker for various diseases.

Current Understanding of TENM4

TENM4 is a 14-kDa protein that is expressed in various tissues, including liver, spleen, heart, and blood vessels. It is a member of the KAP family and is involved in the regulation of various physiological processes, including blood clotting, inflammation, and tissue repair.

One of the unique features of TENM4 is its ability to regulate the activity of other KAPs, including ApoA鈪?, ApoE, and ApoC. This ability allows TENM4 to regulate the levels of these proteins and their functions in the body.

In addition, TENM4 has been shown to play a role in the regulation of cellular signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and TENM4 has been shown to be involved in the regulation of TGF-β signaling in various tissues.

Potential Drug Targets

TENM4 is a potential drug target due to its involvement in various physiological processes and its ability to regulate the activity of other proteins. Several studies have identified potential drug targets for TENM4, including:

1. Blood clotting: TENM4 has been shown to regulate the activity of several enzymes involved in blood clotting, including APC, ApoA鈪?, and ApoE. Therefore, targeting these enzymes may be a potential strategy for treating blood clotting disorders.
2. Inflammation: TENM4 has been shown to regulate the activity of several enzymes involved in inflammation, including caspase-1, iNOS, and COX. Therefore, targeting these enzymes may be a potential strategy for treating inflammatory disorders.
3. Tissue repair: TENM4 has been shown to regulate the activity of several enzymes involved in tissue repair, including collagenase, cell division, and migration. Therefore, targeting these enzymes may be a potential strategy for treating injuries and diseases that involve tissue repair.

Biomarkers

TENM4 has the potential to serve as a biomarker for various diseases due to its involvement in various physiological processes. Several studies have shown that TENM4 levels can be affected by a variety of factors, including inflammation, blood clotting, and tissue injury.

For example, studies have shown that TENM4 levels are elevated in individuals with rheumatoid arthritis (RA), a type of inflammatory disease. Additionally, TENM4 levels have been shown to be elevated in individuals with heart disease, a condition that is often associated with inflammation and oxidative stress.

Conclusion

TENM4 is a protein that is involved in various physiological processes and has the potential to serve as a drug target or biomarker for various diseases. Further research is needed to fully understand the functions and interactions of TENM4 in the body, including its potential drug targets and biomarkers.

Protein Name: Teneurin Transmembrane Protein 4

Functions: Involved in neural development, regulating the establishment of proper connectivity within the nervous system. Plays a role in the establishment of the anterior-posterior axis during gastrulation. Regulates the differentiation and cellular process formation of oligodendrocytes and myelination of small-diameter axons in the central nervous system (CNS) (PubMed:26188006). Promotes activation of focal adhesion kinase. May function as a cellular signal transducer (By similarity)

The "TENM4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TENM4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TENT2 | TENT4A | TENT4B | TENT5A | TENT5B | TENT5C | TENT5C-DT | TENT5D | TEP1 | TEPP | TEPSIN | TERB1 | TERB2 | TERC | TERF1 | TERF1P3 | TERF2 | TERF2IP | TERLR1 | TERT | TES | TESC | TESK1 | TESK2 | TESMIN | TESPA1 | TET1 | TET2 | TET2-AS1 | TET3 | Tetraspanin | TEX10 | TEX101 | TEX11 | TEX12 | TEX13A | TEX13B | TEX13C | TEX14 | TEX15 | TEX19 | TEX2 | TEX21P | TEX22 | TEX26 | TEX261 | TEX264 | TEX28 | TEX29 | TEX30 | TEX33 | TEX35 | TEX36 | TEX36-AS1 | TEX37 | TEX38 | TEX41 | TEX43 | TEX44 | TEX45 | TEX46 | TEX47 | TEX48 | TEX49 | TEX50 | TEX52 | TEX53 | TEX55 | TEX56P | TEX9 | TF | TFAM | TFAMP1 | TFAP2A | TFAP2A-AS1 | TFAP2A-AS2 | TFAP2B | TFAP2C | TFAP2D | TFAP2E | TFAP4 | TFB1M | TFB2M | TFCP2 | TFCP2L1 | TFDP1 | TFDP1P2 | TFDP2 | TFDP3 | TFE3 | TFEB | TFEC | TFF1 | TFF2 | TFF3 | TFG | TFIID Basal Transcription Factor Complex | TFIIIC2 complex | TFIP11 | TFIP11-DT